正在读取抄底盘 · Loading Dip Watch…
正在读取抄底盘 · Loading Dip Watch…
$0.08 · 5 sessions -28.8% · 2026-11-13 16:17 UTC
View full stock details →No trading signal: verified US-equity daily bars and a quote are required.
The conclusion first, followed by the evidence that matters most.
ENTRY CONCLUSION
The valuation margin of safety, technical confirmation and market/estimate conditions are not all satisfied. No entry signal is issued.
The research does not currently establish an actionable entry price. Do not buy solely because the stock has fallen sharply; wait for the key conditions to be verified before reconsidering entry.
PARA is in a high-risk mix of restructuring, financing, and continued-listing pressure: the company completed a 1-for-10 reverse split and received a Nasdaq non-compliance/delisting notice, while also closing an approximately $13.5 million financing on 2026-11-05 with about $5.512 million in net proceeds. The stock jumped sharply on 2026-11-12 on extreme volume, but that looks like event-driven volatility rather than something that offsets weak fundamentals, uncertain appeal outcomes, or further dilution risk. Disclosed terms still allow additional dilution through enlarged authorized share capacity, warrant reset features, and a zero-exercise-price option. With no reliable operating forecast basis, no valuation scenarios are constructed.
Research as of 2026-11-13T03:06:54.614Z · Research conclusion, not a real-time trading signal
Company events, industry developments and market conditions — facts separated from possible explanations.
US 10Y yield 5.13%2026-11-13T16:23:04.000Z
VIX 20.652026-11-13T16:23:01.000Z
Dollar index 103.332026-11-13T16:28:11.000Z
PARA -18.91% · SPY -0.97%
2026-11-13T16:17:11.000Z · Yahoo · Aligned-session reference, not a causal attribution.
Business quality, financials, valuation and analyst disagreements.
Target-price summary $24.00–$24.00 · Consensus $24.00
Buy / hold / sell 1 / 0 / 0
Nasdaq · Retrieved 2026-11-13T16:40:52.166Z · The aggregate does not provide individual report dates or original theses. It does not establish undervaluation; no analyst rationale is inferred. Targets are not guaranteed outcomes.
Next-quarter EPS estimate (Sep 2026) $-12.20 · $-12.20–$-12.20 · 1 analysts
Four-week estimate revisions: up / down 0 / 0
Estimate dispersion 0.0%
Nasdaq EPS forecasts · retrieved 2026-11-13T16:40:52.138Zgpt-5.4-mini · 2026-11-13T03:06:54.614Z · AI-generated and checked, not an independent human audit
Cash: 5.512 USD_millions · 2026-11-05
“The Company received net proceeds of approximately $5.512 million from the Offering, after deducting the Offering expenses payable by the Company, including the Underwriter’s discounts and commissions.”
Additional equity funding: 0 USD_millions · 2026-11-05
“The Company intends to use the net proceeds from the Offering for working capital and other general corporate purposes, and repayment of indebtedness.”
Trend, moving averages, volume and key price levels — not the decline alone.
Conditions for reconsidering entry and developments that invalidate the thesis.